RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Overview

This protocol presents a detailed procedure to apply RNA-seq, a powerful next-generation DNA sequencing technology, to profile transcriptomes in human pulmonary microvascular endothelial cells with or without thrombin treatment. The method includes RNA isolation, library construction, sequencing, and data analysis.

Key Study Components

Area of Science

• Neuroscience
• Genomics
• Cell Biology

Background

• RNA-seq is a next-generation sequencing technology.
• It allows for comprehensive transcriptome profiling.
• Thrombin treatment can affect gene expression in endothelial cells.
• This method can be applied to various cell types and conditions.

Purpose of Study

• To provide a detailed RNA-seq protocol for endothelial cells.
• To identify differentially expressed gene transcripts.
• To validate RNA-seq results through RT-PCR.

Methods Used

• Isolation of total RNA from human pulmonary microvascular endothelial cells.
• Quality checking of RNA samples.
• Construction of DNA libraries from RNA samples.
• Sequencing using the HighSeq 1000 platform.

Main Results

• Identification of differentially expressed gene transcripts.
• Validation of RNA-seq results using RT-PCR.
• Demonstration of RNA-seq advantages over traditional methods.
• Provision of digital data for comprehensive transcriptome analysis.

Conclusions

• RNA-seq is a powerful tool for transcriptome analysis.
• The protocol is applicable to various cell types and conditions.
• It provides a complete profile of gene expression without prior genomic knowledge.

Frequently Asked Questions